Publications

464 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. GVS advice empagliflozin (Jardiance®) extension List 2 conditions

    At the request of the Minister of Health, Welfare and Sport (VWS), The National Health Care Institute will assess whether the ...

    Report | 31-01-2023

  2. GVS advice dexamethasone/levofloxacin eye drops (Ducressa®) for use by adults after cataract surgery

    The National Health Care Institute has assessed whether dexamethasone/levofloxacin (Ducressa®) can be included in the Medicine ...

    Report | 25-01-2023

  3. GVS advice PCV15 (Vaxneuvance®) to prevent severe progression of pneumococcal disease in people in medical high-risk groups

    The National Health Care Institute has assessed whether the 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15, ...

    Report | 25-01-2023

  4. GVS advice odevixibat (Bylvay®) for the treatment of progressive familial intrahepatic cholestasis

    The National Health Care Institute has assessed whether odevixibat (Bylvay®) can be included in the Medicine Reimbursement System ...

    Report | 18-01-2023

  5. GVS advice solriamfetol (Sunosi®) for the treatment of narcolepsy or obstructive sleep apnoea

    The National Health Care Institute has completed its assessment whether the medicinal product solriamfetol (Sunosi®) can be ...

    Report | 23-12-2022

  6. Appendix to guideline for cost-effectiveness models in R - packages and versions

    Appendix to guideline for cost-effectiveness models in R - packages and versions.

    Publication | 15-12-2022

  7. Guideline for building cost-effectiveness models in R

    Guideline for building cost-effectiveness models in R.

    Publication | 15-12-2022

  8. GVS advice fostamatinib (Tavlesse®) for the treatment of chronic immune thrombocytopenia

    The National Health Care Institute has completed its assessment whether the medicinal product fostamatinib (Tavlesse®) is ...

    Report | 06-12-2022

  9. GVS advice doxylamine succinate/pyridoxine hydrochloride (Xonvea®) for the treatment of nausea and vomiting during pregnancy

    The National Health Care Institute has completed its assessment whether the medicinal product doxylamine succinate/pyridoxine ...

    Report | 29-11-2022

  10. GVS advice baloxavir marboxil (Xofluza®)

    The National Health Care Institute has completed its assessment whether the product baloxavir marboxil (Xofluza®) is ...

    Report | 24-11-2022